市場調查報告書
商品編碼
1410774
人工硬腦膜市場:按細分市場劃分的規模、份額、法律法規、報銷、程序、到 2033 年的預測Dura Substitutes Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
人工硬腦膜是修復硬腦膜時用作片材或材質的補片。閉合或修復硬腦膜對於防止腦脊髓液(CSF)滲漏至關重要。
生物人工硬腦膜具有進行血管和上皮融合的能力,有助於其與天然硬腦膜整合。這種類型的替代硬腦膜的加工方式是去除所有細胞和抗原,並且不存在疾病傳播的可能性。由於這些原因,神經血管外科醫生更喜歡使用生物硬腦膜而不是合成硬腦膜。生物硬腦膜替代物具有良好的拉伸強度,使得補片植入後穩定。
該報告深入探討了全球人造硬腦膜市場,包括競爭格局、SWOT 分析、到 2033 年的市場預測、COVID-19 的影響以及區域和國家趨勢。
Dura Substitutes Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Neurology Devices therapeutic area.
The model discusses in detail the impact of COVID-19 on Dura Substitutes market for the year 2020 and beyond. Dura Substitutes are patches which are used as sheet or material in repairing the dura mater. Closure or repair of dura mater is essential to prevent a Cerebrospinal Fluid (CSF) Leak.
The model considers two types of dura substitutes, biological and synthetic. Biological dura substitutes have the ability to undergo vascular and epithelial fusion which helps them to integrate with the native dura mater. This type of substitute is processed so that all cells and antigens are removed and chances of disease transmission is nil. For this reason, neurovascular surgeons prefer using biological dura substitutes over synthetic dura substitutes. The latter have good tensile strength which provides stability to the patch after implantation.
Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed Dura Substitutes and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered - Integra LifeSciences Corp, B. Braun Melsungen AG, Medtronic Plc, DePuy Synthes Inc, Regenity Biosciences, Baxter International Inc and Others
Countries covered - United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -
Not Applicable
Not Applicable
Not Applicable